Bluebird Bio Inc. (BLUE) Surged To Over A 9-Month High

Goldman Sachs announced Thursday morning that it has added bluebird bio Inc. (BLUE) to its Conviction Buy list, with a price target of $135.

from RTT - Before the Bell http://ift.tt/2ctn3Um
via IFTTT